Cargando…
B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants
Aim: Haemodynamically significant patent ductus arteriosus (hsPDA) is frequently observed in premature infants. This study was conducted to explore whether the blood BNP can be a valuable biomarker to assess the necessity of treatment for hsPDA in premature infants. Methods: Serial measurements of t...
Autores principales: | Mine, Kenji, Ohashi, Atsushi, Tsuji, Shoji, Nakashima, Jun-ichi, Hirabayashi, Masato, Kaneko, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798123/ https://www.ncbi.nlm.nih.gov/pubmed/23611593 http://dx.doi.org/10.1111/apa.12273 |
Ejemplares similares
-
Management of Patent Ductus Arteriosus in Premature Infants in 2020
por: Parkerson, Sarah, et al.
Publicado: (2021) -
Case of Patent Ductus Arteriosus
por: Harrington, Archibald W.
Publicado: (1914) -
The Wide Patent Ductus Arteriosus
por: Aitken, G. J.
Publicado: (1955) -
Patent Ductus Arteriosus Device Embolization
por: Iqbal, K, et al.
Publicado: (2011) -
Pharmacological closure of the patent ductus arteriosus
por: Mehta, SK, et al.
Publicado: (2003)